|
|
 News Archive
Latest article: |
|
|
Recent articles: |
|
Universal Assays for Serine-Threonine andTyrosine Kinases
04 Feb 2010: The HTRF® KinEASE™ assay platform for screening serine/threonine kinases (STKs) is now extended to Tyrosine kinases (TKs). Developed in collaboration with Millipore, the HTRF® KinEASE™ reagents are ready-to-use kits based on Cisbio’s patented HTRF® technology and validated on over 160 Ser/Thr and Tyr kinases.
Cisbio Bioassays
|
HTRF® Human SIRT1 Assay: A New Solution for HDAC/SIRT Screening
30 Jan 2010: The HTRF SIRT1 assay is a homogeneous solution for measuring SIRT1 activity. SIRT1, associated with class III of HDACs, has been identified as a regulator of a variety of biological processes, such as glucose homeostasis, mitochondria biogenesis, adipogenesis, apoptosis, senescence and metabolism.
Cisbio Bioassays
|
Cisbio international Announces Launch of HTRF® KinEASE™ TK at SBS
17 Apr 2007: Cisbio international, a global developer of HTRF® technology and services used in assay development and drug screening, announced the launch of HTRF® KinEASE™ TK today at the SBS Conference in Montreal, Canada.
Cisbio Bioassays
|
Assessment of Human Tumor Necrosis Factor alpha in Cell Culture using the HTRF® TNFα Assay
17 Jan 2007: This application note describes the use the HTRF® TNFa assay for measuring TNFα in whole cells and the assays validation in a 384-well format.
Cisbio Bioassays
|
Cisbio international Expands List of Serine/Threonine Kinases Validated using HTRF® KinEASE™
25 Aug 2006: Cisbio international, a global developer of HTRF® technology and services used in assay development and drug screening, announced today that it has expanded the list of kinases validated using its universal HTRF® KinEASE™ platform to include 34 additional kinases.
Cisbio Bioassays
|
|
|
|
|
|
|
 |
|
|
|
